Aldeyra Therapeutics to Host Conference Call and Webcast to Release Expanded Results from Allergen Chamber Trial and Announce Design of Phase 3 INVIGORATE Trial in Patients with Allergic Conjunctivitis
Event scheduled for
The dial-in numbers are (866) 211-4098 for domestic callers and (647) 689-6613 for international callers. A live webcast of the conference call will also be available on the Investor Relations section of the
After the live webcast, the event will remain archived on the
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20191030006009/en/
Source:
Corporate Contact:
David McMullin
Aldeyra Therapeutics, Inc.
Tel: 781-761-4904 ext. 218
dmcmullin@aldeyra.com
Investor & Media Contact:
Scott Solomon
Sharon Merrill Associates, Inc.
Tel: 617-542-5300
ALDX@investorrelations.com